Teladoc Health (NYSE:TDOC) Price Target Lowered to $20.00 at Barclays

Teladoc Health (NYSE:TDOC) had its target price lowered by stock analysts at Barclays from $25.00 to $20.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm currently has an “overweight” rating on the health services provider’s stock. Barclays‘s price target points to a potential upside of 51.17% from the company’s previous close.

A number of other brokerages also recently issued reports on TDOC. Needham & Company LLC reissued a “hold” rating on shares of Teladoc Health in a report on Friday. Cantor Fitzgerald started coverage on Teladoc Health in a research report on Thursday, February 29th. They set an “overweight” rating and a $22.00 target price on the stock. Truist Financial reduced their price target on Teladoc Health from $23.00 to $17.00 and set a “hold” rating for the company in a report on Wednesday, March 6th. Canaccord Genuity Group lowered their price target on Teladoc Health from $28.00 to $25.00 and set a “buy” rating on the stock in a research report on Friday. Finally, Piper Sandler cut their price objective on Teladoc Health from $30.00 to $25.00 and set an “overweight” rating for the company in a research report on Wednesday, February 21st. Eight analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $21.62.

Teladoc Health Stock Performance

Shares of NYSE TDOC traded down $0.10 during trading on Friday, reaching $13.23. 3,465,501 shares of the company traded hands, compared to its average volume of 4,744,668. Teladoc Health has a 12-month low of $12.65 and a 12-month high of $30.41. The company has a current ratio of 3.54, a quick ratio of 3.47 and a debt-to-equity ratio of 0.66. The stock has a market cap of $2.24 billion, a P/E ratio of -9.97 and a beta of 0.94. The firm’s fifty day simple moving average is $15.17 and its 200 day simple moving average is $17.80.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.47) by ($0.02). Teladoc Health had a negative net margin of 8.47% and a negative return on equity of 9.22%. The company had revenue of $646.13 million for the quarter, compared to analysts’ expectations of $637.31 million. During the same quarter in the prior year, the business posted ($0.37) earnings per share. The firm’s revenue was up 2.7% compared to the same quarter last year. As a group, research analysts anticipate that Teladoc Health will post -1.07 earnings per share for the current fiscal year.

Insider Activity

In related news, COO Michael Willem Waters sold 4,523 shares of the business’s stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $19.18, for a total transaction of $86,751.14. Following the transaction, the chief operating officer now directly owns 38,570 shares in the company, valued at $739,772.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Teladoc Health news, insider Arnnon Geshuri sold 7,500 shares of the company’s stock in a transaction on Monday, March 25th. The stock was sold at an average price of $15.06, for a total value of $112,950.00. Following the completion of the sale, the insider now directly owns 38,470 shares in the company, valued at approximately $579,358.20. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, COO Michael Willem Waters sold 4,523 shares of Teladoc Health stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $19.18, for a total value of $86,751.14. Following the transaction, the chief operating officer now owns 38,570 shares in the company, valued at approximately $739,772.60. The disclosure for this sale can be found here. Insiders sold 135,441 shares of company stock worth $2,038,251 over the last three months. Insiders own 1.63% of the company’s stock.

Hedge Funds Weigh In On Teladoc Health

Several institutional investors and hedge funds have recently bought and sold shares of TDOC. Commonwealth Equity Services LLC lifted its stake in shares of Teladoc Health by 5.7% in the 3rd quarter. Commonwealth Equity Services LLC now owns 80,934 shares of the health services provider’s stock valued at $1,505,000 after purchasing an additional 4,344 shares during the last quarter. Robeco Institutional Asset Management B.V. boosted its stake in Teladoc Health by 49.4% during the third quarter. Robeco Institutional Asset Management B.V. now owns 453,861 shares of the health services provider’s stock worth $8,437,000 after buying an additional 149,976 shares during the period. Raymond James & Associates increased its position in shares of Teladoc Health by 0.9% during the third quarter. Raymond James & Associates now owns 228,238 shares of the health services provider’s stock valued at $4,243,000 after acquiring an additional 2,029 shares during the last quarter. Mackenzie Financial Corp raised its stake in shares of Teladoc Health by 83.7% in the 3rd quarter. Mackenzie Financial Corp now owns 30,843 shares of the health services provider’s stock valued at $570,000 after acquiring an additional 14,050 shares during the period. Finally, Allspring Global Investments Holdings LLC lifted its holdings in shares of Teladoc Health by 8.8% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 50,903 shares of the health services provider’s stock worth $946,000 after acquiring an additional 4,129 shares during the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.